ArticleFrontiers in cellular and infection microbiology2024

Immunogenicity and safety of the fourth dose of quadrivalent human papillomavirus (HPV) vaccine in immunosuppressed women who did not seroconvert after three doses.

Lívia Zignago Moreira Dos Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.